Group 1 - Legendary Entertainment is considering acquiring Lionsgate Studios, which has recently spun off its operations [1] - Moelis & Company investment bank is involved in early discussions between Lionsgate and Legendary regarding potential co-productions [2] - Lionsgate has a market capitalization of $2 billion, and its share prices increased by 20% following the initial report of acquisition talks [3] Group 2 - Lionsgate's business model involves offloading foreign films, which limits potential buyers from obtaining full ownership of its library [4] - The company has maintained success in the streaming market by acting as a content provider rather than launching its own OTT service [5] - Legendary's CEO indicated plans to utilize Apollo's funds for significant acquisitions in the entertainment sector [6]

Apple had a box-office hit with "F1," the car-racing movie. Now it looks like it's going to double up on the sport, with a likely deal to stream Formula 1 races. The tech company appears to be the leading bidder for the US rights to show F1 races. The rights are currently held by Disney's ESPN.Apple has submitted a bid worth at least $150 million a year to stream the races starting in 2026. And ESPN isn't going to try to match or beat that, according to a source familiar with negotiations. So barring a la ...

Odyssey has continued to dominate as the #1 Putter for over 25 years on every major worldwide Tour. The Hockey Stick has also been one of the most famous putters in golf lore for nearly 30 years, and this updated model is available in an enhanced design with the unique shape, Odyssey's best technologies, plus a new Happy Gilmore 2-inspired sock headcover. Callaway's Chrome Tour Golf Ball family has been an incredible success in the market and at the professional level with 4 major wins to date, led by an in ...

TORONTO, July 10, 2025 (GLOBE NEWSWIRE) -- Enthusiast Gaming Holdings Inc. (TSX: EGLX) (“Enthusiast Gaming” or the “Company”) today announces a debt financing and forbearance transaction (the “Transaction”) designed to support the Company’s recapitalization and long-term business objectives. Following the Company’s announcement of the strategic divestment of its direct sales business line, Enthusiast Gaming has sharpened its focus on its portfolio of high-performing digital gaming media assets that deliver ...

WUHAN, China, July 9, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that its L2+ standard electro-hydraulic steering system, a power steering system used in heavy-duty vehicles that utilizes both hydraulic power and electronic controls to assist with steering, has entered mass production in China.  Following the iRCB 's outstanding performance and cost-efficiency demonstrated in ...

Environmental Impact of Basketball Waste - The industry produces 40 to 50 million basketballs annually, enough to fill an auditorium 10 times over [2] - A staggering 95% of basketballs end up in landfills or are burned [2] - Discarded basketballs decompose into toxic microplastics, polluting soil, water, and air [3] Consumer Behavior and Waste Generation - A survey at YCIS indicates the average student owns almost two basketballs, with some owning six or more [4] - This consumption pattern contributes to a global waste problem [4] Proposed Solutions for Sustainability - Encourage consumers to extend the lifespan of their basketballs [6] - Promote repairing damaged basketballs instead of discarding them [6] - Support recycling or donation programs, such as Wilson's Rebound, to repurpose old basketballs [6] - Advocate for reduced consumption of new basketballs [6]

Summary of Key Points from the Conference Call Industry Overview - **Industry**: Medical Technology in Japan - **Research Firm**: Morgan Stanley MUFG Securities Co., Ltd. - **Analysts**: Ryotaro Hayashi, Erina Tokunaga - **Industry View**: In-Line [1][4] Companies Discussed 1. **Terumo (4543)** - **Sales**: Y1.04 trillion for F3/25, with segments including Cardiac & Vascular, Medical Care Solutions, and Blood & Cell Technologies [8] - **Key Topics**: Official reimbursement prices for medical devices have seen significant reductions, with average price changes ranging from -1% to -15% across various products [19] 2. **Olympus (7733)** - **Sales**: Y997.3 billion for F3/25, with segments including Endoscopic Solutions and Therapeutic Solutions [25] - **Key Innovations**: Introduction of new endoscopy series "EVIS X1" and a cloud-based digital endoscopy suite "OLYSENSE" [42] 3. **Sysmex (6869)** - **Sales Breakdown**: Hematology (Y303.2 billion, 60% of sales), with a market share of 54% [43][44] - **Recent Developments**: Launch of an In Vitro test for Alzheimer's disease [45] 4. **M3 (2413)** - **Sales**: Y284.9 billion for F3/25, focusing on medical platforms and evidence solutions [52] - **Key Topic**: Development of AI-powered, cloud-based EHR systems to enhance medical care efficiency [56] 5. **Asahi Intecc (7747)** - **Sales**: Y107.5 billion for F6/24, with a focus on medical components and OEM [60] - **Market Share**: Dominates PTCA guidewire market in Japan [63] 6. **Nihon Kohden (6849)** - **Sales**: Breakdown includes patient monitors and physiological measuring equipment [71] 7. **JMDC (4483)** - **Sales**: Y41.7 billion for F3/25, focusing on healthcare big data and telemedicine [76] 8. **Nipro (8086)** - **Sales**: Y644.6 billion for F3/25, with a significant portion from dialysis-related products [79] - **Market Share**: Holds 36% of the global market for dialyzers [82] 9. **H.U. Group Holdings (4544)** - **Sales**: Y243.0 billion for F3/25, focusing on In Vitro Diagnostics [86] 10. **PHC Holdings (6523)** - **Sales**: Y361.6 billion for F3/25, with segments in diabetes management and diagnostics [100] 11. **Hogy Medical (3593)** - **Key Topic**: Sales by product categories, including premium kits and conventional products [115] 12. **Tauns Laboratories (197A)** - **Market Share**: Significant presence in domestic antigen tests for infectious diseases [123] 13. **EUCALIA (286A)** - **Sales**: Y19.8 billion for 2024, focusing on medical management support [128] Important Trends and Insights - **Price Reductions**: Many medical devices are experiencing price reductions, impacting revenue and margins across the industry [19] - **Innovation**: Companies are focusing on technological advancements, such as AI in healthcare and new medical devices, to maintain competitive advantages [42][56] - **Market Dynamics**: The medical technology sector in Japan is characterized by strong competition and significant market shares held by leading companies [44][63][82] Conclusion The medical technology industry in Japan is evolving with significant sales figures reported by major companies. Innovations and price adjustments are key themes, indicating a dynamic market landscape.

Key Takeaways Teleflex completed its 760 million euro acquisition of BIOTRONIK's Vascular Intervention business. The deal expands TFX's interventional access line and supports resorbable scaffold tech development. The acquisition is expected to add $0.10 to TFX's adjusted EPS in year one, with a rising impact thereafter.Teleflex (TFX) recently completed its previously announced acquisition of the majority of BIOTRONIK SE & Co. KG’s Vascular Intervention business. The acquisition significantly expands the ...

要闻提示 NEWS REMIND 1.李想首次回应发飙事件：因当时有人弄虚作假，承认自己脾气大 2.蔚来李斌谈产业升级：以前做车能卖20万就感觉突破了天花板，现在ET9能卖80万 3.正浩CTO陈熙离职，或将创业 4 . 雷军：着急用车可考虑小鹏理想Model Y，拦截YU7大可不必 5 . 荣耀高管谈上市进展：IPO辅导目前很顺利，稳步推进中 6.哪吒汽车关联公司20亿股权遭二次冻结，母公司进入破产重整程序 7.曝iPhone 18系列升级2nm芯片：苹果迈入2nm时代 8.传Intel CEO陈立武考虑放弃推销18A工艺！全力发展Intel 14A 今日头条 HEADLINE NEWS 李想首次回应发飙事件：因当时有人弄虚作假，承认自己脾气大 7月2日，在最新一期《对话》栏目预告中，理想汽车创始人李想称，描述他最准的一个词是"脾气大"。主 持人提到，李想曾在节目中发过一次"著名的脾气"，李想回应称："当时发飙是因为有人在弄虚作假，节 目把后面的话剪掉了。"李想还透露，自己发脾气总共有三种状况：第一种状况是表达一个东西毫无逻 辑；第二种是要求太低，大家得过且过；三是做的事情违背了公司的价值观。 据报道，李想 ...

Acclarent AERA® Eustachian Tube Balloon Dilation System First Patient Enrolled in Acclarent AERA® Pediatric Registry PRINCETON, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Corporation (Nasdaq: IART), a leading global medical technology company, is proud to announce enrollment of the first patient in the Acclarent AERA Pediatric Registry, a prospective, multi-center observational registry evaluating the real-world use of the AERA Eustachian Tube Balloon Dilation System in childre ...